The Cell Sciences Imaging Facility (CSIF) offers state-of-the-art fluorescence and electron microscopy services to Stanford Cancer Institute researchers. The facility provides investigators with advanced imaging systems to image and analyze the molecular and structural organization of cells and tissue at a microscopic level, crucial for researchers studying the biological mechanisms involved in cancer. The CSIF operates at two sites on the Stanford campus, one at the Beckman Center and the other at the newly built Shriram Center for bioengineering across the street from the medical campus. Both locations are available to all SCI researchers. The CSIF is directed by Jon Mulholland, an experienced microscopist and cell biologist, who oversees its day-to-day management. CSIF occupies a combined total of 3,000 square feet in the Shriram and Beckman centers, and employs five full-time research scientists to assist SCI investigators with microscopy needs. The two imaging facilities have ten advanced light and electron microscope systems that provide confocal, deconvolution, 2-photon and super resolution, as well as electron microscopy technologies. For electron microscopy, the CSIF maintains a full-service laboratory that offers sample preparation and training for both transmission and scanning electron microscopy technologies. Over the last five years, the CSIF has been awarded approximately $2.4 million in instrumentation grants from the NIH's Shared Instrument Grant program. In addition, it has received over $2.2 million in internal instrumentation funding, bringing the total award amount to $4.6 million. The facility operates on a cost-recovery basis, with ongoing expenses recovered primarily through user fees; the resource?s annual operating costs are approximately $1,050,000. Since 2009, over 95 SCI members from all research programs have used the CSIF, with the majority of usage coming from the Cancer Stem Cells, Cancer Biology, TOPS and Immunology & Immunotherapy Programs. Future goals of the CSIF include developing and providing correlative electron to light imaging as well as large volume 3D and array tomography imaging. Further, CSIF plans to apply for the 2015 NIH SIG program for two types of advanced instrumentation: one for an advanced SEM system for serial block face SEM that will enable large volume, 3-dimensional reconstruction of tissue at high enough resolution and second for a bio-AFM that combines advanced atomic force measurements with epifluorescence light imaging modalities that will enable characterization of a cell's mechanobiology and protein/molecular composition.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA124435-13
Application #
9936147
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Pollom, Erqi L; Fujimoto, Dylann K; Han, Summer S et al. (2018) Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival. J Radiat Res 59:i11-i18
Nørgaard, Caroline Holm; Jakobsen, Lasse Hjort; Gentles, Andrew J et al. (2018) Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study. PLoS One 13:e0193249
Im, Hogune; Rao, Varsha; Sridhar, Kunju et al. (2018) Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells. Leuk Lymphoma 59:2952-2962
Huang, Min; Zhu, Li; Garcia, Jacqueline S et al. (2018) Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget 9:11665-11676
Chiou, Shin-Heng; Dorsch, Madeleine; Kusch, Eva et al. (2018) Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Sci Rep 8:14008
Breslow, David K; Hoogendoorn, Sascha; Kopp, Adam R et al. (2018) A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies. Nat Genet 50:460-471
Chu, Lisa W; Till, Cathee; Yang, Baiyu et al. (2018) Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. Mol Carcinog 57:462-466
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442

Showing the most recent 10 out of 322 publications